EVERSFIELD REGULATORY LIMITED

Executive Summary

EVERSFIELD REGULATORY LIMITED is financially stable with a strong cash position and positive net assets, reflecting good short-term financial health. The company's lean operational model currently limits scalability but ensures manageable overheads. Strategic growth through team expansion and profitability monitoring will enhance future financial resilience and business sustainability.

EVERSFIELD REGULATORY LIMITED - Analysis Report

Company Number: 14528057

Analysis Date: 2025-07-29 13:44 UTC

Financial Health Assessment of EVERSFIELD REGULATORY LIMITED as at 31 December 2024

---

1. Financial Health Score: B

Explanation:
EVERSFIELD REGULATORY LIMITED demonstrates solid financial footing with positive net assets and a healthy liquidity position. The company shows stable growth in net assets and working capital, reflecting prudent financial management. However, the absence of any employees and minimal fixed assets suggest an early-stage or lean operational model, which limits its resilience and scalability potential. The small scale and limited operational history temper the rating from an A to a B.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets	£10,407	Low asset base, typical for an IT consultancy startup.
Current Assets (Cash)	£69,041	Strong cash position; provides liquidity buffer.
Current Liabilities	£18,090	Manageable short-term obligations.
Net Current Assets (Working Capital)	£50,951	Healthy positive working capital; indicates good short-term financial health.
Net Assets (Shareholders’ Funds)	£61,358	Positive net worth, indicating solvency.
Employee Count	0 (average)	No employees, may indicate reliance on contractors or owner-managed operations.
Profit & Loss Information	Not disclosed	Lack of profit data limits insight into operational profitability.

Interpretation:

• Healthy Cash Flow Analogy: The company’s cash acts like a healthy heartbeat, pumping liquidity to meet short-term needs without stress.
• Asset Base: The low fixed asset value is like a lightweight skeleton — it supports operations but limits physical capacity.
• Working Capital: The positive net current assets are a sign of good “circulation,” ensuring the company can cover its immediate bills comfortably.
• No Employees: This is a symptom that the business may be in a developmental or consulting phase with minimal overhead.

---

3. Diagnosis

EVERSFIELD REGULATORY LIMITED appears financially stable and solvent with increasing net asset value from £55,519 in 2023 to £61,358 in 2024. The company maintains a solid cash reserve, which is critical for liquidity and operational continuity. The increase in net current assets indicates improved ability to cover short-term liabilities, a positive sign of financial wellness.

However, the absence of employees points to a very lean operation, possibly owner-run or reliant on subcontractors, which may limit growth capacity and operational scaling. The lack of disclosed profit and loss data (common in small companies' filings) restricts deeper analysis of profitability and operational efficiency, which are key to long-term viability.

---

4. Recommendations

• Monitor Cash Flow Regularly: Maintain the healthy liquidity position to avoid any symptoms of financial distress, especially in growth phases or during client acquisition cycles.
• Consider Building a Team: To scale operations and increase service capacity, carefully plan recruitment or subcontractor arrangements. This will help convert regulatory expertise into sustainable revenue streams.
• Profit & Loss Transparency: Though not required, consider preparing internal profitability reports to better track financial performance and identify areas for growth or cost control.
• Asset Investment: Evaluate opportunities to acquire or upgrade technology or software tools to enhance service delivery, which could strengthen the fixed asset base and operational capacity.
• Risk Management: Keep a close watch on liabilities and tax obligations to avoid surprises; maintain compliance rigorously given the regulatory consultancy focus.

---